The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CIMAC-CIDC tissue imaging harmonization.
 
Guray Akturk
No Relationships to Disclose
 
Edwin Roger Parra Cuentas
No Relationships to Disclose
 
Ana Lako
Employment - Bristol-Myers Squibb
 
Evisa Gjini
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Beatriz Sanchez Espiridion
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - AstraZeneca/MedImmune; Asuragen; Bayer; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Merck; MSD Oncology; OncoCyte; Pfizer
Speakers' Bureau - MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Adaptive Biotechnologies (Inst); Akoya Biosciences (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Iovance Biotherapeutics (Inst); Johnson & Johnson (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); OncoPlex Diagnostics (Inst); Pfizer (Inst); Silicon Biosytems (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; MSD Oncology; Pfizer
 
Magdalena Thurin
No Relationships to Disclose
 
Stephen M. Hewitt
Patents, Royalties, Other Intellectual Property - Fixatives (Inst); Tissue Microarray Device (Inst)
 
Scott Rodig
Honoraria - Bristol-Myers Squibb; Perkin Elmer
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Affimed Therapeutics; Bristol-Myers Squibb; Kite, a Gilead company; Merck
Patents, Royalties, Other Intellectual Property - Patent pending for use of Anti-galectin1 antibodies for diagnostic use.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Jiexin Zhang
No Relationships to Disclose
 
Donna S. Neuberg
Stock and Other Ownership Interests - Madrigal Pharmaceuticals
Research Funding - Pharmacyclics
 
J. Jack Lee
Consulting or Advisory Role - Abbvie
 
Sacha Gnjatic
Consulting or Advisory Role - B4CC; Bristol-Myers Squibb; Merck; Neon Therapeutics; OncoMed; Third Rock Ventures
Research Funding - Agenus; Immune Design; Janssen; Pfizer; Regeneron; Takeda
Patents, Royalties, Other Intellectual Property - Patent on Multiplex Immunohistochemistry with Chromogen Staining on a Single Slide (MICSSS); Patents related to immune composition of NY-ESO-1 and peptides.
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics; NanoString Technologies; Novartis